The co-chairs of HIV Research for Prevention (HIVR4P 2018), the world’s only scientific meeting dedicated exclusively to biomedical HIV prevention, have announced that the 2018 Desmond Tutu Award for HIV Prevention Research and Human Rights will be presented to HIV researcher, physician and community advocate Linda-Gail Bekker of Cape Town, South Africa. The presentation will take place at the Opening Plenary of this year’s HIVR4P conference, Monday 22 October in Madrid, Spain.
Congratulations to Dr. Joseph Raimondo and his team for receiving the Wellcome Trust Seed Award. Seed Awards help researchers develop novel ideas that will go on to form part of larger grant applications to Wellcome or elsewhere.
The Academy of Science of South Africa (ASSAf) recognised two of South Africa’s foremost scholars with gold medals at its prestigious Annual Awards Ceremony held in Pretoria on 10 October 2018. ASSAf annually awards ASSAf Science-for-Society Gold Medals for outstanding achievement in scientific thinking to the benefit of society. This year the awards were presented to physician-scientist, Professor Linda-Gail Bekker, and palaeoanthropologist, Professor Lee Berger.
Twenty of the country’s leading scholars and scientists were inaugurated as Members of the Academy of Science of South Africa (ASSAf) at the annual Awards Ceremony on 10 October 2018. As the official Academy of South Africa, ASSAf has as core function to honour the country’s most outstanding scholars by electing them to Membership of the Academy. ASSAf Members are drawn from the full spectrum of disciplines. New Members are elected each year by the full existing Membership. Membership of the Academy is a great honour and is in recognition of scholarly achievement. Members are the core asset of the Academy and give of their time and expertise voluntarily in the service of society.
CIDRI-Africa Contributing and Principal Investigators A/Prof. Helen Cox and Prof. Valerie Mizrahi's editorial on genomic approaches to Mtb drug susceptibility testing was published yesterday in the New England Journal of Medicine.
A primary analysis published in the New England Journal of Medicine shows positive results in a clinical trial conducted in tuberculosis-endemic regions.
We are seeking applicants for one PhD fellowship position: the successful candidate will be based within the Division of Clinical Pharmacology at UCT. The incumbent will work under the joint supervision of Professor Gary Maartens, Head of Division, and Professor David Haas, Vanderbilt University, US.
The prestigious SAMRC Scientific Merit Awards gala event was held on 30 August 2018 in Cape Town. The annual event, a highlight in South Africa’s health calendar, recognises and celebrates leading health research through a set of established medal awards.
Newton Mobility one-year awards are intended to strengthen the research capacity/capability of, and contribute to promoting economic development and social welfare in, the overseas country. The awards will also initiate the development of longer-term links between the overseas and UK researchers.
Awards might include a range of related activities, but mobility (in the form of visits and exchanges, etc.) should form an integral part of proposals. The main purpose of the funding is to cover travel and maintenance costs, although costs related to other eligible activities will be considered. Partnerships including a training element and involving scholars in the early stages in their career will be looked on favourably.
The Fogarty HIV-associated Tuberculosis Training Program is calling for applications for two PhD fellowship opportunities in Basic and Clinical Science.
Travel bursaries are available for the Wellcome Centre for Anti-Infectives Research Conference which takes place on 12 - 15 May 2019 at the University of Dundee, UK. The bursary will cover conference registration and a contribution towards travel costs up to £1000-£1500.
Scientists from South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced publication in the New England Journal of Medicine of the results of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents.